ZBIO Dividend History & Analysis | N/A Yield
ZBIO has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| BTX | 1,397 M | 13.4% | 7.37% |
| ABBV | 393,809 M | 3.64% | 9.76% |
| GILD | 150,721 M | 2.55% | 6.71% |
| AMGN | 174,694 M | 2.87% | 5.0% |
| HLN | 44,084 M | 1.77% | 2.46% |
| Symbol | Market Cap USD | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BTX | 1,397 M | 203% | 90.0% |
| GRFS | 7,645 M | 127% | 56.8% |
| BIM | 15,056 M | 45.4% | 92.6% |
| HLN | 44,084 M | 51.0% | 100% |
| AMGN | 174,694 M | 8.90% | 100% |
Similar Stocks with Attractive Dividends - Compare ZBIO Dividends with its Peer-Group
3.64% Yield
2.87% Yield
2.55% Yield
1.77% Yield
ZBIO Dividend History: as of December 2025
No dividends paid yet.ZBIO Dividend FAQ
Zenas BioPharma, Inc. (NASDAQ:ZBIO) is a clinical-stage biopharma focused on immunology-based therapeutics. Its flagship candidate, obexelimab, is a bifunctional monoclonal antibody that simultaneously targets CD19 and FcγRIIb, positioning it for indications such as IgG4-related disease, multiple sclerosis, and systemic lupus erythematosus. The pipeline also includes ZB002 (anti-TNFα), ZB004 (CTLA-4-Ig fusion), and ZB001 (anti-IGF-1R), all aimed at leveraging novel immune-modulation mechanisms. The company, incorporated in 2019 and headquartered in Waltham, MA, rebranded from Zenas BioPharma (Cayman) Limited in August 2023.
What is the Dividend Yield of ZBIO?
As of December 2025, ZBIO`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 42.33.Does ZBIO pay a dividend?
As of December 2025 ZBIO does not pay a dividend.How often does ZBIO pay dividends?
Over the last 12 months, ZBIO has issued dividend payments.ZBIO dividend forecast
Based on historical data, the forecasted dividends per share for ZBIO for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will ZBIO pay dividends in 2025?
The next Ex-Dividend date for Zenas BioPharma, Common (ZBIO) is currently unknown.What is the next Ex-Dividend Date for ZBIO?
The next Ex-Dividend date for Zenas BioPharma, Common (ZBIO) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of ZBIO?
ZBIO's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of ZBIO?
ZBIO's 5-Year Yield on Cost is -%. If you bought ZBIO's shares at 18.15 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of ZBIO?
ZBIO Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does ZBIO have a good Dividend Yield?
ZBIO`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of ZBIO?
The Dividend Payout Ratio of ZBIO is unknown.What is the Dividend Rating of ZBIO?
ZBIO`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-11-26 02:40